Riskpilot← Back to searchSign inGet full accessPrimeMed AB
ABActiveOrg 5568404817Storbogatan 10 BGeneral medical practice activities · NACE 8621Est. 20111 employees
Revenue 2025
SEK 0
EBITDA margin
—
-146% vs 2024
Equity ratio
74.5%
Financial strength
Net profit 2025
SEK -25K
-160% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -24K | -146% |
| Net profit | SEK -25K | -160% |
| Total assets | SEK 109K | -44% |
| Equity | SEK 81K | -48% |
| Employees | 1 | — |
Legal name
PrimeMed AB
Org number
5568404817
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
2 februari 2011
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Medicinsk verksamhet inom både offentlig och privat sektor. Utbildare och konsult inom både sjukvård och andra profilområden såsom IT, ledarskap, idrottsmedicin. Datakonsulttjänster. Kurs- och eventarrangör. Försäljning av sjukvårdsartiklar och annan utrustning. Köp och försäljning av värdepapper (aktier, fonder & obligationer).
Address
Storbogatan 10 B
Phone
+46739804120
Email
marcus.carlsson@primemed.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 311 | 351 | 451 | 80 | 0 |
| Staff expenses | — | −12 | −25 | −2 | −0 |
| EBITDA | 263 | 300 | 368 | 53 | −24 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 263 | 300 | 368 | 53 | −24 |
| Net financials | — | 0 | −0 | −1 | −1 |
| Profit before tax | 263 | 300 | 368 | 52 | −25 |
| Tax | −55 | −62 | −77 | −11 | — |
| Net profit | 208 | 238 | 291 | 41 | −25 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 343 | 348 | 457 | 196 | 109 |
| Equity | 266 | 294 | 364 | 155 | 81 |
| Long-term debt | 0 | 0 | 0 | — | — |
| Short-term debt | 77 | 54 | 93 | 40 | 28 |
| Total debt | 77 | 54 | 93 | 40 | 28 |
EBITDA margin
-2407200.0%
This company
15.8%
Market median
-15235543% vs market
20212025
Equity ratio
74.5%
This company
38.2%
Market median
+95% vs market
20212025
Return on equity
-30.4%
This company
18.4%
Market median
-265% vs market
20212025
Net profit margin
-2458300.0%
This company
8.1%
Market median
-30349483% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.34×
This company
0.62×
Market median
+45% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
LG Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2022 |
MT Chief Executive Officer | Chief Executive Officer | 2021 |
| Former (1) | ||
AK Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2021 – 2022 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of PrimeMed AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lars Göran Carlsson | Deputy Chief Executive Officer | 0 companies |
| Marcus Tobias Carlsson | Chief Executive Officer | 0 companies |
| Anna Kristina Carlsson | Deputy Chief Executive Officer | 0 companies |